NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
Clinical Trials
5 trialsNCT00079001 2020-05-12
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00499408 2018-11-21
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00329797 2017-11-29
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00585637 2015-04-01
Vitamin D for Chemoprevention
Dana-Farber Cancer Institute
Phase 1 Completed